Thomas Stephen Basil 4
4 · Climb Bio, Inc. · Filed Jul 1, 2025
Insider Transaction Report
Form 4
Climb Bio, Inc.CLYM
Thomas Stephen Basil
Director
Transactions
- Exercise/Conversion
Common Stock
2025-06-27+25,094→ 204,282 total - Exercise/Conversion
Restricted Stock Units
2025-06-27−25,094→ 0 total→ Common Stock (25,094 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The RSUs were granted on June 27, 2024 and vested as to 50% of the shares on January 1, 2025, vested as to 25% of the shares on March 27, 2025 and vested as to the remaining 25% of the shares on June 27, 2025, subject to the Reporting Person's continued service.